Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
WCI-TV Interview with Kim Radcliffe
In this WCI-TV interview, Kim Radcliffe explains how direct access to PT helps injured employees recover faster, with fewer missed workdays and lower costs.
Collision Claims for Battery Electric Vehicles Shrink for the First Time in the U.S. While Hybrid Claims Surge
Mitchell today announced the release of its latest Plugged-In: EV Collision Insights report. The Q2 2025 edition examines the decrease in collision claims frequency for repairable battery electric vehicles (BEVs) in the U.S. and increase in mild hybrid electric vehicle (MHEV) claims across North America. It also explores how changes to government incentive programs are impacting consumer adoption of BEVs on both sides of the border.
Plugged-In: EV Collision Insights Q2 2025
Claims frequency for repairable, collision-damaged battery electric vehicles (BEVs) fell for the first time in the U.S.—dropping to 2.92% last quarter, a decrease of 7%. This decline coincided with a 6.3% reduction in new BEV purchases compared to Q2 2024 despite record-breaking sales earlier in the year. Consumer demand is being tested as federal tax incentives are set to expire in September while discounts for electrified options reached an all-time high of nearly $8,500 per automobile by the end of the quarter.
Top 10 Essential Factors to Consider When Choosing a Medical Records Summarization Vendor
When entrusting a vendor with your medical records summarization needs, speed will get you a quick summary but integrating clinical insight with AI processes is a necessity to support well-informed claims decisions. The right vendor understands how AI cannot replace human insight and leverages both to help protect your organization from costly errors.
Accelerating Recovery: The Case for Direct Physical Therapy Access in Workers’ Comp
Enlyte SVP Kim Radcliffe shares why direct physical therapy access should be a frontline strategy in workers’ comp. Learn how it reduces delays, lowers costs, and improves return-to-work outcomes.
Enlyte Celebrates National Adjuster Day With Clinician-Reviewed Medical Records Tool to Ease Claims Burden
Adjusters are often considered the foundation of insurance industry success, but their vital role is often underappreciated. So, once again, Enlyte is celebrating these professionals in honor of National Adjuster Day, Aug. 17, by launching another product designed to make their lives easier.